Published by Unseen Progress, an independent publisher of caregiver research. Last reviewed 2026-05-10. Part of the stroke caregiver research overview.
Short answer. The "neuroplasticity window" is not a door that slams shut at six months. The research describes a sensitive period in the first 3–6 months when spontaneous biological recovery and heightened cortical plasticity converge (Krakauer et al., 2012; Cramer, 2008), and then a slower but indefinite phase of experience-dependent plasticity that continues for years (Winstein et al., 2016; Kleim & Jones, 2008). Most families are told the first version and never the second, which leads them to abandon home protocols at exactly the wrong moment.
Gert Kwakkel's longitudinal modelling of post-stroke recovery describes a steep curve in the first 3 months, a flattening between 3 and 6 months, and a long tail of slower gains beyond that (Kwakkel et al., 2006). About 70% of measurable functional recovery, on average, occurs inside the first three months — but average is not destiny, and "70% by month 3" is not the same as "0% after month 6."
John Krakauer and colleagues describe the early phase as a sensitive period of heightened plasticity, in which cortical reorganisation is biologically easier and rehabilitation dose has the highest per-hour return (Krakauer et al., 2012). This is why intensive, task-specific therapy in the first 3 months is so emphasised in stroke guidelines: the per-rep gain is genuinely larger when the cortex is still in its most plastic state.
What the same body of work makes clear is that plasticity does not stop at the end of the sensitive period. Steven Cramer's review of experience-dependent plasticity (Cramer, 2008) and the Kleim and Jones principles of experience-dependent plasticity (Kleim & Jones, 2008) describe the same mechanism — repeated, specific, salient practice driving cortical change — operating through the chronic phase. The 2016 AHA/ASA Adult Stroke Rehabilitation Guidelines explicitly state that motor, language, and cognitive recovery can continue well past 6 months with appropriate therapy intensity (Winstein et al., 2016).
This is the phase where spontaneous recovery and intensive rehabilitation overlap. The research strongly supports getting therapy dose as high as the survivor can tolerate without compromising rest and mood. Inpatient and early outpatient rehab are deliberately front-loaded for exactly this reason. A family caregiver's job in this window is mostly to protect the dose — get the survivor to therapy, support practice between sessions, and avoid letting fatigue or low mood quietly reduce participation.
Recovery curves flatten — but flattening is not stopping. Kwakkel's data shows continuing measurable gains in this window, just at a slower per-week rate. This is the phase where most caregivers lose confidence, because day-to-day change becomes invisible. The temptation to conclude "they've stopped improving" is strongest here, and is most often wrong.
Beyond six months, plasticity is governed primarily by the Kleim and Jones principles: use it or lose it, use it and improve it, specificity, repetition, intensity, time, salience, age, transference, interference (Kleim & Jones, 2008). Translating: motor, language, and cognitive gains continue, but only for skills that are practised, specifically, at sufficient dose, on tasks the survivor cares about. Generic activity does not produce specific recovery.
When a clinician or caregiver says "the window has closed," they almost always mean one of the following — none of which is the same as "plasticity has ended":
1. Insurance or service-system limits have ended, so formal rehab is no longer being delivered. 2. The patient has plateaued on the current protocol, which often responds to a change in modality (CIMT for an upper limb, intensive aphasia therapy block, treadmill training) rather than to time alone. 3. Spontaneous biological recovery has ended, which is true around 3–6 months — but experience-dependent recovery has not. 4. Effort has dropped below threshold, typically because no one can see the gains and motivation has eroded.
Each of these has a different solution, and none is well-served by accepting "the window has closed" at face value.
In months 0–3, maximise tolerable therapy dose, protect sleep and mood as preconditions for plasticity, and start writing down concrete markers (gait speed, words per dinner sentence, grip strength, hours of unprompted speech) so you have a baseline.
In months 3–6, keep the home protocol going at consistent dose. Re-check the markers from month 0 and month 3. Even a small directional improvement at month 6 is meaningful — it is the slower phase doing exactly what the research predicts.
In months 6–12, if formal therapy ends, do not abandon practice. Convert the rehab homework into a sustainable home routine. Consider asking the team about a structured change — constraint-induced movement therapy, an aphasia therapy block, treadmill training, a different cognitive task — because the chronic phase frequently responds to intensity and modality changes that families assume are no longer worth trying.
Beyond 12 months, treat plateaus as protocol problems first, ceiling problems second. The literature has many cases of meaningful gains in the second and third year following stroke when intensity or specificity was raised (Wolf et al., 2006 on CIMT in chronic-phase survivors; Page et al., 2012 on modified CIMT).
The research-backed answer to "is the window closed?" is to change one variable and give it 60–90 days of consistent practice before concluding anything. Specifically:
1. Identify one specific skill the survivor wants to improve (saying their grandchild's name, walking to the mailbox, buttoning a shirt). 2. Pick one evidence-supported practice approach for that skill — task-specific repetition is the default; CIMT for upper-limb non-use; intensive aphasia therapy blocks for language. 3. Define a measurable marker. Re-check at 30 and 60 days. 4. If the marker has moved at all in 60 days, you are still inside the window. Continue.
---
Unseen Progress publishes long-form caregiver research and builds research-backed daily trackers for the families covered. See the full stroke caregiver research overview for the complete framework.